CTLA-4 checkpoint inhibitor (University of Texas at El Paso/University of Toronto/University of Pisa)

N/A

Report date: 2025/03/18 18:12:45

Base Information

Drug NameCTLA-4 checkpoint inhibitor (University of Texas at El Paso/University of Toronto/University of Pisa)
Drug Alias NameAnti-CTLA-4 mAb (University of Texas at El Paso/University of Toronto/University of Pisa)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionCytotoxic T-Lymphocyte-Associated Antigen 4 inhibitors
TargetsCytotoxic T-Lymphocyte-Associated Antigen 4
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesItaly
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity of Toronto
China Registration ClassN/A

Develop Information

Active CompaniesUniversity of TorontoUniversity Of PisaUniversity Of Texas At El Paso Acc Soc
Inactive CompaniesN/A
Active IndicationsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A